India’s capacity to scale next-generation biologics draws focus at BioAsia 2026
(From left) Winselow Tucker (president and GM of Lilly India), Stefan Miltenyi (founder CEO and president of Miltenyi Biotec, Germany), G.V.Prasad (co-chairman & MD of Dr. Reddy’s Laboratories), Eric Mansion (GM, India & South-East Asia of Sanofi, Singapore) and Shreehas Tambe (MD and CEO of Biocon Biologics) at a panel discussion during BioAsia 2026 in…
Read More “India’s capacity to scale next-generation biologics draws focus at BioAsia 2026” »

